Filing Details
- Accession Number:
- 0001450324-18-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-12-03 11:32:56
- Reporting Period:
- 2018-11-30
- Accepted Time:
- 2018-12-03 11:32:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 946644 | Hemispherx Biopharma Inc | HEB | Biological Products, (No Disgnostic Substances) (2836) | 520845822 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1450324 | K. Thomas Equels | 2117 Sw Highway 484 Ocala FL 34473 | Exec. Vice Chairman/Ceo/Pres. | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-11-30 | 1,354 | $0.19 | 779,661 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 5 | $0.19 | 779,666 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 9,557 | $0.19 | 789,223 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 2,400 | $0.19 | 791,623 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 50 | $0.19 | 791,673 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 300 | $0.19 | 791,973 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 334 | $0.19 | 792,307 | No | 4 | P | Direct | |
| Common Stock | Acquisiton | 2018-11-30 | 6,000 | $0.20 | 798,307 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
